TOPADUR PHARMA AG Announces Daniel L. Vasella, M.D. as Newly Appointed Board Member
Zurich-Schlieren, Switzerland, July 1, 2020. The shareholders of the company elected today Dr. Daniel L. Vasella, – former CEO and President of NOVARTIS – as new members to the Board of Directors of Topadur Pharma AG.
“I am extremely happy with the election of Dr. Vasella to the Board of Directors. His visionary leadership and his dedication to deliver transformative treatments to help patients is impressive and deeply aligns with our mission. With his medical background he complements the board at the right time when we begin the clinical development with TOP-N53, a promising drug candidate to enable wound healing” said Reto Naef, Chairman of the Board of Directors and CEO at TOPADUR.